Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Carlos Suarez

9PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Molecular targetsCancer cell biologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Nov 06, 2025
Liposarcoma and Leiomyosarcoma as the First Manifestation of Familial Retinoblastoma: Implications for Genetic Testing and Carrier Surveillance.

Claire Johns, Molly McGuinness, Kerry Kingham

|May 26, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.

Paul A Wadsworth, Simon B Chen, Lauren Lawrence

|Feb 14, 2023
Therapeutic Implications of Oncogenic Missense <i>HER2</i> (<i>ERBB2</i>) Mutations in Gastric Adenocarcinoma.

Daniel A King, Julianna J Weiel, Rochelle Reyes

|Oct 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Pamela L Kunz, Noah T Graham, Paul J Catalano

|Oct 14, 2022
Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts.

Anuja Sathe, Kaishu Mason, Susan M Grimes

|Mar 05, 2022
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.

Bethany L Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu

Pageof 2

Frequent Collaborators

2 joint publications

James M Ford

2 joint publications

George A Fisher

2 joint publications

Anuja Sathe

1 joint publications

Robert J Huang

1 joint publications

Michael S Khodadoust

1 joint publications

Youn H Kim

1 joint publications

Kerri E Rieger

1 joint publications

Youssef Youssef

1 joint publications

Gabrielle Ernst

1 joint publications

Kevin G Wu

Frequent Collaborators

2 joint publications

James M Ford

2 joint publications

George A Fisher

2 joint publications

Anuja Sathe

1 joint publications

Robert J Huang

Top Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on : Jun 13, 2018

9.2K
A Scalable, Cell-Based Method for the Functional Assessment of <em>Ube3a</em> Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of <em>Ube3a</em> Variants

Published on : Oct 10, 2022

2.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
See more related videos

Top Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on : Jun 13, 2018

9.2K
A Scalable, Cell-Based Method for the Functional Assessment of <em>Ube3a</em> Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of <em>Ube3a</em> Variants

Published on : Oct 10, 2022

2.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
See more related videos